EUVIMEDEUVIMED entdecken
Crossref

Updated Review of HOMA-IR (Homeostatic Model Assessment for Insulin Resistance)

Jayachidambaram Ambalavanan

Evidence to Action: Official Journal of MDCalc · 2025

DOI: 10.65357/001c.154184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Evidence to Action: Official Journal of MDCalc, 2025. Verfasst von Jayachidambaram Ambalavanan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HOMA-IR is used to estimate prevalence of insulin resistance in individuals who are at risk of developing metabolic syndrome and diabetes. This review summarizes pearls, pitfalls and practical application of the calculator.

Zitieren

APA

Ambalavanan, J. (2025). Updated Review of HOMA-IR (Homeostatic Model Assessment for Insulin Resistance). Evidence to Action: Official Journal of MDCalc. https://doi.org/10.65357/001c.154184

Vancouver

Ambalavanan J. Updated Review of HOMA-IR (Homeostatic Model Assessment for Insulin Resistance). Evidence to Action: Official Journal of MDCalc. 2025. doi:10.65357/001c.154184

BibTeX
@article{Ambalavanan2025,
  author = {Ambalavanan, Jayachidambaram},
  title = {Updated Review of HOMA-IR (Homeostatic Model Assessment for Insulin Resistance)},
  journal = {Evidence to Action: Official Journal of MDCalc},
  year = {2025},
  doi = {10.65357/001c.154184}
}
Kostenlos starten →